Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO
Your search for supplemental oxygen returned 11 results
No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen
Annual respiratory syncytial virus-associated hospitalization rates varied from 35.7 to 132.3 per 1000 children aged younger than 6 months.
Gohibic is supplied as a 200mg/20mL solution in a single-dose vial for IV infusion after dilution.
Researchers examined the epidemiology and clinical outcomes of sporadic health care-associated respiratory syncytial virus infection in children.
InflaRx is working to increase supply of the product in the US as quickly as possible.
Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo
The studies evaluated routine clinical practice data from more than 800 hospitals in the US.
Lower average oxygen delivery rates seen in association with Asian, Black, Hispanic versus White race, ethnicity
Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.